Heterogeneous pathologies associated with dementia in Parkinsonism share a prion-like spreading mechanism

Archives Italiennes de Biologie

Volumn 151, Issue 4, 2013, Pages 169-178

  Candela, S ^a   Giubilei, F ^a   Orzi, F ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Dementia; Neurocognitive disorders; Parkinsonism; Prion propagation

Indexed keywords

EID: 84901294589     PISSN: 00039829     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Aarsland D., Ballard C., Larsen J.P., McKeith I. A comparative study of psychiatric symptoms in dementia with Lewy bodies and Parkinson's disease with and without dementia. Int. J. Geriatr. Psychiatry, 16: 528-536, 2001
2. Aarsland D., Andersen K., Larsen J.P., Lolk A., Kragh-Sorensen P. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch. Neurol., 60: 387-392, 2003a
3. Aarsland D., Litvan I., Salmon D., Galasko D., Wentzel-Larsen T., Larsen J.P. Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry, 74: 1215-1220, 2003b
4. Ala T.A., Yang K.-H., Sung J.H., Frey W.H. Hallucinations and signs of parkinsonism help distinguish patients with dementia and cortical Lewy bodies from patients with Alzheimer's disease at presentation: a clinicopathological study. J. Neurol. Neurosurg. Psychiatry, 62: 16-21, 1997
5. Angot E., Steiner J.A., Hansen C., Li J.Y., Brundin P. Are synucleinopathies prion-like disorders? Lancet Neurol., 9: 1128-1138, 2010
6. Armstrong M.J., Litvan I., Lang A.E., Bak T.H., Bhatia K.P., Borroni B., Boxer A.L., Dickson D.W., Grossman M., Hallett M., Josephs K.A., Kertesz A., Lee S.E., Miller B.L., Reich S.G., Riley D.E., Tolosa E, Tröster A.I., Vidailhet M., Weiner W.J. Criteria for the diagnosis of corticobasal degeneration. Neurology, 80: 496-503, 2013
7. Ballard C., Holmes C., McKeith I., Neill D., O'Brien J., Cairns N., Lantos P., Perry E., Ince P., Perry R. Psychiatric morbidity in dementia with Lewy bodies: a prospective clinical and neuro pathological comparative study with Alzheimer's disease. Am. J. Psychiatry, 156: 1039-1045, 1999
8. Benson D.F., Davis R.J., Snyder B.D. Posterior cortical atrophy. Arch. Neurol., 45: 789-793, 1988
9. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol., 82: 239-259, 1991
10. Braak H., Del Tredici K., Bratzke H., HammClement J., Sandmann-Keil D., Rüb U. Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages). J. Neurol., 249 (Suppl. 3): 1-5, 2002
11. Burack M.A., Hartlein J., Flores H.P., TaylorReinwald L., Perlmutter J.S., Cairns N.J. In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia. Neurology, 74: 77-84, 2010
12. Chaudhuri K.R. and Schapira A.H. Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. Lancet Neurol., 8: 464- 474, 2009
13. Clavaguera F., Bolmont T., Crowther R.A., Abramowski D., Frank S., Probst A., Fraser G., Stalder A.K., Beibel M., Staufenbiel M., Jucker M., Goedert M., Tolnay M. Transmission and spreading of tauopathy in transgenic mouse brain. Nat. Cell Biol., 11: 909-913, 2009
14. Desplats P., Lee H.J., Bae E.J., Patrick C., Rockenstein E., Crews L., Spencer B., Masliah E., Lee S.J. Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc. Natl. Acad. Sci. USA, 106: 13010-13015, 2009
15. ®. Diagnostic and Statistical Manual of Mental Disorders. 1994, American Psychiatric Association, Fourth Edition
16. DSM-5. Diagnostic and Statistical Manual of Mental Disorders. 2013, American Psychiatric Association, Fifth Edition
17. Doherty K.M., Silveira-Moriyama L., Parkkinen L., Healy D.G., Farrell M., Mencacci N.E., Ahmed Z., Brett F.M., Hardy J., Quinn N., Counihan T.J., Lynch T., Fox Z.V., Revesz T., Lees A.J., Holton J.L. Parkin disease: a clinicopathologic entity? JAMA Neurol., 70: 571-579, 2013
18. Emre M., Aarsland D., Brown R., Burn D.J., Duyckaerts C., Mizuno Y., Broe G.A., Cummings J., Dickson D.W., Gauthier S., Goldman J., Goetz C., Korczyn A., Lees A., Levy R., Litvan I., McKeith I., Olanow W., Poewe W., Quinn N., Sampaio C., MD, Tolosa E., Dubois B. Clinical Diagnostic criteria for dementia associated with Parkinson's disease. Mov. Disord., 22: 1689-1707, 2007
19. Ferman T.J., Smith G.E., Boeve B.F., Ivnik R.J., Peterson R.C., Knopman D., Graff-Radford N., Parisi J., Dickson D.W. DLB fluctuations: specific features that reliably differentiate DLB from AD and normal aging. Neurology, 62: 181-187, 2004
20. Fevrier B., Vilette D., Archer F., Loew D., Faigle W., Vidal M., Laude H., Raposo G. Cells release prions in association with exosomes. Proc. Natl. Acad. Sci. USA, 101: 9683-9688, 2004
21. Fritze F., Ehrt U., Hortobagyi T., Ballard C., Aarsland D. Depressive symptoms in Alzheimer's disease and lewy body dementia: a one-year follow-up study. Dement Geriatr. Cogn. Disord., 32: 143- 149, 2011
22. Frost B. and Diamond M.I. Prion-like mechanisms in neurodegenerative diseases. Nat. Rev. Neurosci., 11: 155-159, 2010
23. Giasson B.I., Forman M.S., Higuchi M., Golbe L.I., Graves C.L., Kotzbauer P.T., Trojanowski J.Q., Lee V.M. Initiation and synergistic fibrillization of tau and alpha-synuclein. Science, 300: 636-640, 2003
24. Halliday G.M., Holton J.L., Revesz T., Dickson D.W. Neuropathology underlying clinical variability in patients with synucleinopathies. Acta Neuropathol., 122: 187-204, 2011
25. Halliday G.M., Song Y.J, Harding A.J. Striatal SymbolMT.-1.c69-amyloid in dementia with Lewy bodies but not Parkinson's disease. J. Neural. Transm., 118: 713- 719, 2011
26. Hansen C. and Li J.Y. Beyond alpha-synuclein transfer: pathology propagation in Parkinson's disease. Trends Mol. Med., 18: 248-255, 2012
27. Hawkes C.H., Del Tredici K., Braak H. Parkinson's disease: the dual hit theory revisited. Ann. N.Y. Acad. Sci., 1170: 615-622, 2009
28. Hirono N., Mori E., Tanimukai S., Kazui H., Hashimoto M., Hanihara T., Imamura T. Distinctive neurobehavioral features among neurodegenerative dementias. J. Neuropsychiatry Clin. Neurosci., 11: 498-503, 1999
29. Irwin D.J., White M.T., Toledo J.B., Xie S.X., Robinson J.L., Van Deerlin V., Lee V.M., Leverenz J.B., Montine T.J., Duda J.E., Hurtig H.I., Trojanowski J.Q. Neuropathologic substrates of Parkinson disease dementia. Ann. Neurol., 72: 587-598, 2012
30. Johnson J.K., Head E., Kim R., Starr A., Cotman C.W. Clinical and pathological evidence for a frontal variant of Alzheimer disease. Arch. Neurol., 56: 1233-1239, 1999
31. Johnson D.K., Morris J.C., Galvin J.E. Verbal and visuospatial deficits in dementia with Lewy bodies. Neurology, 65: 1232-1238, 2005
32. Josephs K.A., Hodhes J.R., Snowden J.S., Mackenzie I.R., Neumann M., Mann D.M., Dickson D.W. Neuropathological background of phenotypical variability in frontotemporal dementia. Acta Neuropathol., 122: 137-153, 2011
33. Jucker M. and Walker L.C. Pathogenic protein seeding in alzheimer disease and other neurodegenerative disorders. Ann. Neurol., 70: 532-540, 2011
34. Kas A., De Souza L.C., Samri D., Bartolomeo P., Lacomblez L., Kalafat M., Migliaccio R., Thiebaut de Schotten M., Cohen L., Dubois B., Habert M.O., Sarazin M. Neural correlates of cognitive impairment in posterior cortical atrophy. Brain, 134: 1464-1478, 2011
35. Kordower J.H., Dodiya H.B., Kordower A.M., Terpstra B., Paumier K., Madhavan L., Sortwell C., Steece-Collier K., Collier T.J. Transfer of hostderived alpha synuclein to grafted dopaminergic neurons in rat. Neurobiol. Dis., 43: 552-557, 2011
36. Li J.Y., Englund E., Holton J.L., Soulet D., Hagell P., Lees A.J., Lashley T., Quinn N.P., Rehncrona S., Björklund A., Widner H., Revesz T., Lindvall O., Brundin P. Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-tograft disease propagation. Nat. Med., 14: 501-503, 2008
37. Lippa C.F., Duda J.E., Grossman M., Hurtig H.I., Aarsland D., Boeve B.F., Brooks D.J., Dickson D.W., Dubois B., Emre M., Fahn S., Farmer J.M., Galasko D., Galvin J.E., Goetz C.G., Growdon J.H., Gwinn-Hardy K.A., Hardy J., Heutink P., Iwatsubo T., Kosaka K., Lee V.M., Leverenz J.B., Masliah E., McKeith I.G., Nussbaum R.L., Olanow C.W., Ravina B.M., Singleton A.B., Tanner C.M., Trojanowski J.Q., Wszolek Z.K. DLB/PDD Working Group. DLB and PDD boundary issues: diagnoses, treatment, molecular pathology, and biomarkers. Neurology, 68: 812-819, 2007
38. Masuda-Suzukake M., Nonaka T., Hosokawa M., Oikawa T., Arai T., Akiyama H., Mann D.M., Hasegawa M. Prion-like spreading of pathological alpha-synuclein in brain. Brain, 136: 1128-1138, 2013
39. McKeith I.G. and Burn D. Spectrum of Parkinson's disease, Parkinson's dementia, and Lewy body dementia. pp. 865-883. In: DeKosky S.T. (ed.) Neurologic Clinics. Philadelphia, WB Sauders, 2000
40. McKeith I.G., Galasko D., Kosaka K., Perry E.K., Dickson D.W., Hansen L.A., Salmon D.P., Lowe J., Mirra S.S., Byrne E.J., Lennox G., Quinn N.P., Edwardson J.A., Ince P.G., Bergeron C., Burns A., Miller B.L., Lovestone S., Collerton D., Jansen E.N., Ballard C., de Vos R.A., Wilcock G.K., Jellinger K.A., Perry R.H. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology, 47: 1113-1124, 1996
41. McKeith I.G., Burn D.J., Ballard C.G., Collerton D., Jaros E., Morris C.M., McLaren A., Perry E.K., Perry R., Piggott M.A., O'Brien J.T. Dementia with Lewy bodies. Semin. Clin. Neuropsychiatry, 8: 46-57, 2003
42. McKeith I.G., Dickson D.W., Lowe J., Emre M., O'Brien J.T., Feldman H., Cummings J., Duda J.E., Lippa C., Perry E.K., Aarsland D., Arai H., Ballard C.G., Boeve B., Burn D.J., Costa D., Del Ser T., Dubois B., Galasko D., Gauthier S., Goetz C.G., Gomez-Tortosa E., Halliday G., Hansen L.A., Hardy J., Iwatsubo T., Kalaria R.N., Kaufer D., Kenny R.A., Korczyn A., Kosaka K., Lee V.M., Lees A., Litvan I., Londes E., Lopez O.L., Minoshima S., Mizuno Y., Molina J.A., Mukaetova-Landiska E.B., Pasquier F., Perry R.H., Schulz J.B., Trojanowski J.Q., Yamada M., Consortium on DLB. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology, 3: 1863-l872, 2005
43. McKhann G.M., Knopman D.S., Chertkow H., Hyman B.T., Jack C.R., Kawas C.H., Klunk W.E., Koroshetz W.J., Manly J.J., Mayeux R., Mohs R.C., Morris J.C., Rossor M.N., Scheltens P., Carrillo M.C., Thies B., Weintraub S., Phelps C.H. The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging and the Alzheimer's Association workgroup. Alzheimers Dement, 7: 263-269, 2011
44. Mendez I., Viñuela A., Astradsson A., Mukhida K., Hallett P., Robertson H., Tierney T., Holness R., Dagher A., Trojanowski J.Q., Isacson O. Dopamine neurons implanted into people with Parkinson's disease survive without pathology for 14 years. Nat. Med., 14: 507-509, 2008
45. Mesulam M., Wicklund A., Johnson N., Rogalski E., Léger G.C., Rademaker A., Weintraub S., Bigio E.H. Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia. Ann. Neurol., 63: 709-719, 2008
46. Moskowitz M.A., Lo E.H., Iadecola C. The science of stroke: mechanisms in search of treatments. Neuron, 67: 181-198, 2010
47. Morra L.F. and Donovick P.J. Clinical presentation and differential diagnosis of dementia with Lewy bodies: a review. Int. J. Geriatr. Psychiatry, 2013
48. Natale G., Ferrucci M., Lazzeri G., Paparelli A., Fornai F. Transmission of prions within the gut and towards the central nervous system. Prion, 5: 142-149, 2011
49. Noe E., Marder K., Bell K.L., Jacobs D.M., Manly J.J., Stern Y. Comparison of dementia with Lewy bodies to Alzheimer's disease and Parkinson's disease with dementia. Mov. Disord., 19: 60-67, 2004
50. O'Sullivan S.S., Williams D.R., Gallagher D.A., Massey L.A., Silveira-Moriyama L., Lees A.J. Non motor symptoms as presenting complaints in Parkinson's disease: a clinicopathological study. Mov. Disord., 23: 101-106, 2008
51. Paolo A.M., Troster A.I., Glatt S.L., Hubble J.P., Koller W.C. Differentiation of the dementias of Alzheimer's and Parkinson's disease with the dementia rating scale. J. Geriatr. Psychiatry Neurol., 8: 184-188, 1995
52. Parnetti L., Castrioto A., Chiasserini D., Persichetti E., Tambasco N., El-Agnaf O., Calabresi P. Cerebrospinal fluid biomarkers in Parkinson disease. Nat. Rev. Neurol., 9: 131-140, 2013
53. Prusiner S.B. Novel proteinaceous infectious particles cause scrapie. Science, 216: 136-144, 1982
54. Rabinovici G.D., Jagust W.J., Furst A.J., Ogar J.M., Racine C.A., Mormino E.C., O'Neil J.P., Lal R.A., Dronkers N.F., Miller B.L., Gorno-Tempini M.L. Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia. Ann. Neurol., 64: 388-401, 2008
55. Schoonenboom N.S., Reesink F.E., Verwey N.A., Kester M.I., Teunissen C.E., van de Ven P.M., Pijnenburg Y.A., Blankenstein M.A., Rozemuller A.J., Scheltens P., van der Flier W.M. Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort. Neurology, 78: 47-54, 2012
56. Sperling R.A., Karlawish, J., Johnson K.A. Preclinical Alzheimer disease-the challenges ahead. Nat. Rev. Neurol., 9: 54-58, 2013
57. Warren J.D., Fletcher P.D., Golden H.L. The paradox of syndromic diversity in Alzheimer disease. Nat. Rev. Neurol., 8: 451-464, 2012
58. Weisman D. and McKeith I. Dementia with Lewy body. Semin. Neurol., 27: 42-47, 2007
59. Williams-Gray C.H., Foltynie T., Brayne C.E.G., Robbins T.W. and Barker R.A. Evolution of cogni-tive dysfunction in an incident Parkinson's disease cohort. Brain, 130: 1787-1798, 2007
60. Williams D.R. and Lees A.J. Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: a retrospective autopsy study. Lancet Neurol., 4: 605-610, 2005
61. Ziemssen T. and Reichmann H. Non-motor dysfunction in Parkinson's disease. Parkinsonism Relat. Disord., 13: 323-332, 2007